Arch Womens Ment Health October 2024 PMID 38424254

Investigating maternal and neonatal health outcomes associated with continuing or ceasing dexamphetamine treatment for women with attention-deficit hyperactivity disorder during pregnancy: a retrospective cohort study.

Danielle J Russell, Caitlin S Wyrwoll, David B Preen, Erin Kelty

Full text PDF Download social card

Mentions

Peak: 10 in Mar 2024

across 4 sources since Mar 2024

Extended reach

10,226

potential audience

Total likes

253

Video views

5,360

Mentions per month

Mar 2024 – Jul 2025

Where it's discussed

X / Twitter9 posts
News6 articles
YouTube2 videos
Blogs2 articles

AI synopsis

What people are saying

The overall tone reflects a moderately positive perception, with posts such as congratulating the author on the publication and noting the study's focus on maternal and neonatal health outcomes. The words like 'congratulation' and references to 'investigates an ADHD medication during pregnancy' suggest shared excitement and acknowledgment of the research's importance, though the engagement remains at an informational level rather than critical or highly analytical.

AgreementModerate agreement

Most discussions acknowledge the importance of the study, with some expressing cautious support or appreciation for the research focus.

InterestModerate interest

Participants show moderate interest, mainly highlighting the novelty or relevance of examining maternal medication during pregnancy.

EngagementModerate engagement

Comments include congratulatory messages and general summaries, indicating engagement but limited critical analysis.

ImpactModerate impact

The discussions recognize the potential significance of the findings for maternal health practices, but without detailed exploration.

Abstract in brief

ADHD is frequently diagnosed in women, leading to increased use of dexamphetamine during pregnancy, but the safety of its continuation is uncertain.
A study examined women in Western Australia who took dexamphetamine during pregnancy, comparing those who continued the medication to those who stopped before the second trimester and a matched unexposed group.
Results indicated that ceasing the medication led to higher odds of threatened abortion, while the unexposed group experienced lower risks of several adverse health outcomes compared to those who continued taking dexamphetamine.
Overall, continuing dexamphetamine did not result in worse maternal or neonatal outcomes compared to stopping the medication.

Read the full abstract

All mentions

Genetic Risks and Cannabis Use in ADHD: Recent Findings

This video covers recent research on genetic risk factors for ADHD, the increased prevalence of cannabis use disorder among individuals with ADHD, and the implications for treatment and screening practices.

Russell Barkley, PhD - Dedicated to ADHD Science+ · Mar 9, 2024 5,312 views

ADHD Medication Safety During Pregnancy and Impact on Outcomes

This video reviews recent research on the safety of ADHD medications in pregnancy and discusses when continuing treatment may be beneficial. It explains how ADHD medications improve focus, emotion regulation, and daily…

ADHD: Speaking the Un-spoken · Jul 26, 2025 48 views

Kelly A. Hogan Ph.D.

@Loose_Lab_Rat · X

Mar 13, 2024 · 2,239 followers View post →

Elio Sassine

@Elio65 · X

https://t.co/Cgd4we6rrY

Mar 12, 2024 · 411 followers View post →

Archives of Women’s Mental Health

@AWMH_Journal · X

RT @SPGH_UWA: Congratulation to @Daniell36245873 on her first ever published paper

Mar 8, 2024 · 2 shares · 968 followers View post →

Ingrid Stacey

@ingrid_stacey · X

RT @Daniell36245873: My paper from my honours year has recently been published! It investigates an ADHD medication during pregnancy, lookin…

Mar 6, 2024 · 3 shares · 141 followers View post →

Jack Janetzki

@pharmer_jack · X

RT @Daniell36245873: My paper from my honours year has recently been published! It investigates an ADHD medication during pregnancy, lookin…

Mar 6, 2024 · 3 shares · 104 followers View post →

Danielle Russell

@almostdrdani · X

RT @SPGH_UWA: Congratulation to @Daniell36245873 on her first ever published paper

Mar 6, 2024 · 2 shares · 36 followers View post →

UWA School of Population & Global Health

@SPGH_UWA · X

Congratulation to @Daniell36245873 on her first ever published paper

Mar 6, 2024 · 6 likes · 2 shares · 811 followers View post →

Ebony Quintrell

@EbonyQuintrell · X

RT @Daniell36245873: My paper from my honours year has recently been published! It investigates an ADHD medication during pregnancy, lookin…

Mar 6, 2024 · 3 shares · 85 followers View post →

Danielle Russell

@almostdrdani · X

My paper from my honours year has recently been published! It investigates an ADHD medication during pregnancy, looking at maternal and neonatal health outcomes. https://t.co/GVh24072Oo

Mar 6, 2024 · 6 likes · 3 shares · 36 followers View post →

Investigating maternal and neonatal health outcomes associated with continuing or ceasing dexamphetamine treatment for women with attention-deficit hyperactivity disorder during pregnancy: a retrospective cohort study.

Mentions per month

Where it's discussed

What people are saying

Abstract in brief

Top posts

All mentions

Genetic Risks and Cannabis Use in ADHD: Recent Findings

ADHD Medication Safety During Pregnancy and Impact on Outcomes